Prime Minister Mark Carney said Wednesday during a pre-budget speech that Canada’s goal over the next decade is to “double ...

New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the studyAnti-tumour activity observed across all dose levels and in various tumour indicationsNEWCASTLE, ...

Middle-class shoppers flock to brands like The North Face and Dillard's as signs of their material comfort, and they aren't shy about it.

Sarytogan Graphite has secured US$2.2 million from prominent Kazakh investor Dias Sarenov to fast-track the definitive ...

Vizsla Silver's stock has benefited from rising silver prices. Learn more about its Panuco project and its potential.

Data breach-related class actions are a mainstay in U.S. courts and do not appear to be going away any time soon. As with civil litigation generally, most such cases settle rather than proceed to ...

Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating PotentialUNIONDALE, NY, ...

Potential first-in-class, and industry-leading DNA polymerase Theta (Polθ) inhibitor, ART6043 demonstrated an attractive tolerability profile, ...

Detailed price information for Atyr Pharma Inc (ATYR-Q) from The Globe and Mail including charting and trades.

Smackover Lithium, a 55:45 owned Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) ...

Ovid Therapeutics jumps 39% in a month after phase I epilepsy study data show superior efficacy of its lead candidate, OV329, hinting at best-in-class potential.

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today presented positive topline data from Part 1 of ...